CagriSema: A Novel Combination Therapy for Obesity CagriSema is a new weight loss injection from Novo Nordisk, the next step in the evolution of obesity treatments after Ozempic, Wegovy and Mounjaro. This combination therapy has cagrilintide, a long acting amylin analogue and semaglutide, a well known GLP-1 receptor agonist. Together they work synergistically to suppress …
Introduction What is Telemedicine? Telemedicine is using digital technology like smartphones, tablets and computers to deliver health services remotely. Imagine having a doctor’s appointment in your living room or getting health advice through a video call or a mobile app. It’s all about making healthcare more accessible and convenient especially for those who can’t get …
The global obesity epidemic is growing and the competition to develop effective and convenient weight loss treatments is heating up. Recently injectable GLP-1 receptor agonists like Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound have been the stars of the show, delivering impressive weight loss for patients. But the next big thing in obesity treatment is …
When a non-profit organization like Endeavor selects you to be part of its High-Impact Entrepreneurs network, it is not only a recognition to me, but also for all the members of Medtep. The main reason I became an entrepreneur was to change the world. For me, and the entire Medtep team, there is nothing more …